GB Sciences (OTCMKTS:GBLX) Stock In Focus After Recent Development

September 7, 2022

Plant based biopharmaceutical research and medicine developer GB Sciences (OTCMKTS:GBLX) was in the news yesterday following a significant development and that could bring the company’s stock to the radars of investors. Trading Data On Tuesday, GBLX stock moved down 2.34% to $0.0250 with more than 154.88K shares, compared to its average volume of 147.52K shares. The stock moved within a range of $0.0250 – 0.0280 after opening trade at $0.0260….

Read More >>